The UK Perspective

Traditionally patients with low rectal cancers have undergone surgery to remove part of the colon and anal canal, resulting in permanent colostomy. The Papillon 50 can deliver treatment to selective patients with small tumours. This treatment avoids permanent colostomy and has an equivalent success rate to radical surgery.

In the UK over 10,000 rectal cancer cases are reported each year and over a third of these patients are treated with radical surgery requiring permanent colostomy.

It is expected that the impending introduction of a national screening service for rectal cancer will result in earlier diagnosis with significantly more patients being suited for Papillon treatment.

Current equipment has many shortfalls which the Papillon 50 resolves making the technique suitable for use at more Centres throughout the UK.